Artificial intelligence now extracts vital health data from routine heart scans to predict cardiovascular disease risk more accurately. As medical technology improves, AI techniques show great potential for enhancing the timing and efficiency of life-saving diagnoses. A new study suggests that measuring fat around the heart can significantly improve the ability to predict future illnesses.
Researchers at Mayo Clinic followed nearly 12,000 adults for approximately 16 years to track long-term cardiovascular development. They used AI to analyze routine coronary artery calcium (CAC) scans and measure pericardial fat surrounding the heart. This study compared these AI measurements against standard risk assessment tools like the American Heart Association PREVENT equation.
Identifying High-Risk “Gray Zone” Patients
The AI-derived heart fat volume serves as a complementary tool for physicians to stratify patients in uncertain categories. Current tools often categorize a meaningful proportion of patients as “borderline” or intermediate risk during routine evaluations. However, this automated biomarker identifies higher-risk individuals within those groups who actually need more aggressive preventive treatments.
Accurate Predictions Without New Imaging
Importantly, this new diagnostic method does not require any additional imaging beyond what is already performed for patients. Pericardial fat volume predicts cardiovascular events independently, even after accounting for age, blood pressure, and cholesterol levels. Furthermore, researchers found a 24% higher risk among individuals with low coronary calcium if they had high heart fat.
“Pericardial fat’s contribution to predicting cardiovascular outcomes was previously shown in several other studies,” said Zahra Esmaeili, MD, first author and researcher in the Department of Cardiovascular Medicine at Mayo Clinic.
“However, what was notable to us was that this biomarker can add incremental values on top of both traditional risk factors, and coronary calcium scoring, and beyond current risk assessment tools,” Esmaeili noted.
“Specifically, higher pericardial fat volume provided increased value in borderline and intermediate risk patients and showed a 24% higher risk among individuals with low coronary calcium,” she added.
Critical Analysis
The Mayo Clinic study represents a significant leap forward in utilizing artificial intelligence for non-invasive preventive cardiology. By repurposing existing CAC scans, researchers have successfully found a way to add clinical value without increasing patient costs. This data-driven approach specifically addresses the diagnostic “gray zone,” which has long been a challenge for primary care physicians.
However, the medical community must consider the broader implementation of AI tools across diverse healthcare infrastructures. While the 16-year follow-up provides robust evidence, the reliance on specialized AI algorithms may limit accessibility in smaller clinics. Furthermore, while heart fat is a strong independent predictor, it should remain one part of a holistic patient evaluation. Despite these challenges, the ability to identify a 24% higher risk in seemingly low-risk patients is a major victory for early intervention.
Q&A: Redefining Cardiovascular Assessment
Q: How does AI help doctors predict heart disease better?
A: AI extracts detailed fat measurements from routine scans that traditional risk assessment tools might otherwise overlook.
Q: Can heart fat predict risk if my cholesterol is normal?
A: Yes, pericardial fat remains a strong predictor of risk even after accounting for factors like age and cholesterol.
FAQ
What is pericardial fat?
It is the specific layer of fat surrounding the heart that researchers can now measure using AI technology.
Who benefits most from this AI analysis?
Individuals in the “gray zone,” or intermediate-risk category, benefit most from this more precise risk stratification tool.
Does this require extra doctor appointments?
No, the AI analyzes existing scans, meaning no additional imaging or invasive procedures are necessary for the patient.
